Regulation of skeletal muscle mitochondrial function by nuclear receptors: Implications for health and disease

Clinical Science

Volumn 129, Issue 7, 2015, Pages 589-599

  Perez Schindler, Joaquin ^a   Philp, Andrew ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Exercise; Mitochondrial function; Non communicable disease; Nuclear receptor; Skeletal muscle; Transcription factors

Indexed keywords

CELL NUCLEUS RECEPTOR; CHICKEN OVALBUMIN UPSTREAM PROMOTER TRANSCRIPTION FACTOR; ESTROGEN RELATED RECEPTOR; NR4A PROTEIN; NUCLEAR RECEPTOR SUBFAMILY 4 GROUP A; ORPHAN NUCLEAR RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; REV ERB PROTEIN; THYROID HORMONE RECEPTOR; UNCLASSIFIED DRUG; CELL RECEPTOR; OVALBUMIN; TRANSCRIPTION FACTOR;

EXERCISE; HUMAN; MITOCHONDRIAL BIOGENESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SKELETAL MUSCLE; ANIMAL; ANIMAL EXPERIMENT; CHICKEN; GENE EXPRESSION REGULATION; METABOLISM; MITOCHONDRIAL GENOME; MITOCHONDRION; MOUSE; MUSCLE DISEASE; MUSCLE MITOCHONDRION; NON INSULIN DEPENDENT DIABETES MELLITUS; PHYSIOLOGY; RAT;

ANIMALS; CHICKENS; DIABETES MELLITUS, TYPE 2; EXERCISE; GENE EXPRESSION REGULATION; GENOME, MITOCHONDRIAL; HUMANS; MICE; MITOCHONDRIA; MITOCHONDRIA, MUSCLE; MUSCLE, SKELETAL; MUSCULAR DISEASES; OVALBUMIN; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS; PHYSICAL CONDITIONING, ANIMAL; RATS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, THYROID HORMONE; TRANSCRIPTION FACTORS;

EID: 84942863906     PISSN: 01435221     EISSN: 14708736     Source Type: Journal    
DOI: 10.1042/CS20150246     Document Type: Review

References (104)

1. Gostin, L.O. (2014) Non-communicable diseases: Healthy living needs global governance. Nature 511, 147-149
2. Scully, T. (2014) Public health: society at large. Nature 508, S50-S51
3. Zimmet, P.Z., Magliano, D.J., Herman, W.H. and Shaw, J.E. (2014) Diabetes: a 21st century challenge. Lancet Diabetes Endocrinol. 2, 56-64
4. Muoio, D.M. (2014) Metabolic inflexibility: when mitochondrial indecision leads to metabolic gridlock. Cell 159, 1253-1262
5. Petersen, K.F., Dufour, S., Savage, D.B., Bilz, S., Solomon, G., Yonemitsu, S., Cline, G.W., Befroy, D., Zemany, L., Kahn, B.B. et al. (2007) The role of skeletal muscle insulin resistance in the pathogenesis of the metabolic syndrome. Proc. Natl. Acad. Sci. U.S.A. 104, 12587-12594
6. Crescenzo, R., Bianco, F., Mazzoli, A., Giacco, A., Liverini, G. and Iossa, S. (2014) Mitochondrial efficiency and insulin resistance. Frontiers Physiol. 5, 512
7. Holloszy, J.O. (2009) Skeletal muscle 'mitochondrial deficiency' does not mediate insulin resistance. Am. J. Clin. Nutr. 89, 463S-466S
8. Montgomery, M.K. and Turner, N. (2015) Mitochondrial dysfunction and insulin resistance: an update. Endocrine Connect. 4, R1-R15
9. Goodpaster, B.H. (2013) Mitochondrial deficiency is associated with insulin resistance. Diabetes 62, 1032-1035
10. Thyfault, J.P. and Booth, F.W. (2011) Lack of regular physical exercise or too much inactivity. Curr. Opin. Clin. Nutr. Metab. Care 14, 374-378
11. Egan, B. and Zierath, J.R. (2013) Exercise metabolism and the molecular regulation of skeletal muscle adaptation. Cell Metab. 17, 162-184
12. Germain, P., Staels, B., Dacquet, C., Spedding, M. and Laudet, V. (2006) Overview of nomenclature of nuclear receptors. Pharmacol. Rev. 58, 685-704
13. Benoit, G., Cooney, A., Giguere, V., Ingraham, H., Lazar, M., Muscat, G., Perlmann, T., Renaud, J.P., Schwabe, J., Sladek, F., Tsai, M.J. and Laudet, V. (2006) International Union of Pharmacology. LXVI. Orphan nuclear receptors. Pharmacol. Rev. 58, 798-836
14. Nautiyal, J., Christian, M. and Parker, M.G. (2013) Distinct functions for RIP140 in development, inflammation, and metabolism. Trends Endocrinol. Metab. 24, 451-459
15. Mottis, A., Mouchiroud, L. and Auwerx, J. (2013) Emerging roles of the corepressors NCoR1 and SMRT in homeostasis. Genes Dev. 27, 819-835
16. Pérez-Schindler, J. and Handschin, C. (2013) New insights in the regulation of skeletal muscle PGC-1α by exercise and metabolic diseases. Drug Discovery Today: Disease Models 10, e79-e85
17. Salvatore, D., Simonides, W.S., Dentice, M., Zavacki, A.M. and Larsen, P.R. (2014) Thyroid hormones and skeletal muscle-new insights and potential implications. Nat. Rev. Endocrinol. 10, 206-214
18. Flamant, F., Baxter, J.D., Forrest, D., Refetoff, S., Samuels, H., Scanlan, T.S., Vennstrom, B. and Samarut, J. (2006) International Union of Pharmacology. LIX. The pharmacology and classification of the nuclear receptor superfamily: thyroid hormone receptors. Pharmacol. Rev. 58, 705-711
19. Gustafsson, R., Tata, J.R., Lindberg, O. and Ernster, L. (1965) The relationship between the structure and activity of rat skeletal muscle mitochondria after thyroidectomy and thyroid hormone treatment. J. Cell Biol. 26, 555-578
20. Irrcher, I., Adhihetty, P.J., Sheehan, T., Joseph, A.M. and Hood, D.A. (2003) PPARgamma coactivator-1alpha expression during thyroid hormone-and contractile activity-induced mitochondrial adaptations. Am. J. Physiol. Cell Physiol. 284, C1669-1677
21. Bahi, L., Garnier, A., Fortin, D., Serrurier, B., Veksler, V., Bigard, A.X. and Ventura-Clapier, R. (2005) Differential effects of thyroid hormones on energy metabolism of rat slow-and fast-twitch muscles. J. Cell. Physiol. 203, 589-598
22. Branvold, D.J., Allred, D.R., Beckstead, D.J., Kim, H.J., Fillmore, N., Condon, B.M., Brown, J.D., Sudweeks, S.N., Thomson, D.M. and Winder, W.W. (2008) Thyroid hormone effects on LKB1, MO25, phospho-AMPK, phospho-CREB, and PGC-1alpha in rat muscle. J. Appl. Physiol. 105, 1218-1227
23. Puigserver, P., Wu, Z., Park, C.W., Graves, R., Wright, M. and Spiegelman, B.M. (1998) A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell 92, 829-839
24. Amorim, B.S., Ueta, C.B., Freitas, B.C., Nassif, R.J., Gouveia, C.H., Christoffolete, M.A., Moriscot, A.S., Lancelloti, C.L., Llimona, F., Barbeiro, H.V. et al. (2009) A TRbeta-selective agonist confers resistance to diet-induced obesity. J. Endocrinol. 203, 291-299
25. Castillo, M., Freitas, B.C., Rosene, M.L., Drigo, R.A., Grozovsky, R., Maciel, R.M., Patti, M.E., Ribeiro, M.O. and Bianco, A.C. (2010) Impaired metabolic effects of a thyroid hormone receptor beta-selective agonist in a mouse model of diet-induced obesity. Thyroid 20, 545-553
26. Bryzgalova, G., Effendic, S., Khan, A., Rehnmark, S., Barbounis, P., Boulet, J., Dong, G., Singh, R., Shapses, S., Malm, J. et al. (2008) Anti-obesity, anti-diabetic, and lipid lowering effects of the thyroid receptor beta subtype selective agonist KB-141. J. Steroid Biochem. Mol. Biol. 111, 262-267
27. Casas, F., Rochard, P., Rodier, A., Cassar-Malek, I., Marchal-Victorion, S., Wiesner, R.J., Cabello, G. and Wrutniak, C. (1999) A variant form of the nuclear triiodothyronine receptor c-ErbAalpha1 plays a direct role in regulation of mitochondrial RNA synthesis. Mol. Cell. Biol. 19, 7913-7924
28. Casas, F., Pessemesse, L., Grandemange, S., Seyer, P., Gueguen, N., Baris, O., Lepourry, L., Cabello, G. and Wrutniak-Cabello, C. (2008) Overexpression of the mitochondrial T3 receptor p43 induces a shift in skeletal muscle fiber types. PLoS One 3, e2501
29. Casas, F., Pessemesse, L., Grandemange, S., Seyer, P., Baris, O., Gueguen, N., Ramonatxo, C., Perrin, F., Fouret, G., Lepourry, L. et al. (2009) Overexpression of the mitochondrial T3 receptor induces skeletal muscle atrophy during aging. PLoS One 4, e5631
30. Pessemesse, L., Schlernitzauer, A., Sar, C., Levin, J., Grandemange, S., Seyer, P., Favier, F.B., Kaminski, S., Cabello, G., Wrutniak-Cabello, C. et al. (2012) Depletion of the p43 mitochondrial T3 receptor in mice affects skeletal muscle development and activity. FASEB J. 26, 748-756
31. Neels, J.G. and Grimaldi, P.A. (2014) Physiological functions of peroxisome proliferator-activated receptor beta. Physiol. Rev. 94, 795-858
32. Michalik, L., Auwerx, J., Berger, J.P., Chatterjee, V.K., Glass, C.K., Gonzalez, F.J., Grimaldi, P.A., Kadowaki, T., Lazar, M.A., O'Rahilly, S. et al. (2006) International Union of Pharmacology. LXI. Peroxisome proliferator-activated receptors. Pharmacol. Rev. 58, 726-741
33. Brun, S., Carmona, M.C., Mampel, T., Vinas, O., Giralt, M., Iglesias, R. and Villarroya, F. (1999) Activators of peroxisome proliferator-activated receptor-alpha induce the expression of the uncoupling protein-3 gene in skeletal muscle: a potential mechanism for the lipid intake-dependent activation of uncoupling protein-3 gene expression at birth. Diabetes 48, 1217-1222
34. Wu, P., Inskeep, K., Bowker-Kinley, M.M., Popov, K.M. and Harris, R.A. (1999) Mechanism responsible for inactivation of skeletal muscle pyruvate dehydrogenase complex in starvation and diabetes. Diabetes 48, 1593-1599
35. Muoio, D.M., Way, J.M., Tanner, C.J., Winegar, D.A., Kliewer, S.A., Houmard, J.A., Kraus, W.E. and Dohm, G.L. (2002) Peroxisome proliferator-activated receptor-alpha regulates fatty acid utilization in primary human skeletal muscle cells. Diabetes 51, 901-909
36. Ljung, B., Bamberg, K., Dahllof, B., Kjellstedt, A., Oakes, N.D., Ostling, J., Svensson, L. and Camejo, G. (2002) AZ 242, a novel PPARalpha/gamma agonist with beneficial effects on insulin resistance and carbohydrate and lipid metabolism in ob/ob mice and obese Zucker rats. J. Lipid Res. 43, 1855-1863
37. Pickavance, L.C., Brand, C.L., Wassermann, K. and Wilding, J.P. (2005) The dual PPARalpha/gamma agonist, ragaglitazar, improves insulin sensitivity and metabolic profile equally with pioglitazone in diabetic and dietary obese ZDF rats. Br. J. Pharmacol. 144, 308-316
38. Koh, E.H., Kim, M.S., Park, J.Y., Kim, H.S., Youn, J.Y., Park, H.S., Youn, J.H. and Lee, K.U. (2003) Peroxisome proliferator-activated receptor (PPAR)-alpha activation prevents diabetes in OLETF rats: comparison with PPAR-gamma activation. Diabetes 52, 2331-2337
39. Muoio, D.M., MacLean, P.S., Lang, D.B., Li, S., Houmard, J.A., Way, J.M., Winegar, D.A., Corton, J.C., Dohm, G.L. and Kraus, W.E. (2002) Fatty acid homeostasis and induction of lipid regulatory genes in skeletal muscles of peroxisome proliferator-activated receptor (PPAR) alpha knock-out mice. Evidence for compensatory regulation by PPAR delta. J. Biol. Chem. 277, 26089-26097
40. Finck, B.N., Bernal-Mizrachi, C., Han, D.H., Coleman, T., Sambandam, N., LaRiviere, L.L., Holloszy, J.O., Semenkovich, C.F. and Kelly, D.P. (2005) A potential link between muscle peroxisome proliferator-activated receptor-alpha signaling and obesity-related diabetes. Cell Metab. 1, 133-144
41. Norris, A.W., Hirshman, M.F., Yao, J., Jessen, N., Musi, N., Chen, L., Sivitz, W.I., Goodyear, L.J. and Kahn, C.R. (2008) Endogenous peroxisome proliferator-activated receptor-gamma augments fatty acid uptake in oxidative muscle. Endocrinology 149, 5374-5383
42. Tanaka, T., Yamamoto, J., Iwasaki, S., Asaba, H., Hamura, H., Ikeda, Y., Watanabe, M., Magoori, K., Ioka, R.X., Tachibana, K. et al. (2003) Activation of peroxisome proliferator-activated receptor delta induces fatty acid beta-oxidation in skeletal muscle and attenuates metabolic syndrome. Proc. Natl. Acad. Sci. U.S.A. 100, 15924-15929
43. Kleiner, S., Nguyen-Tran, V., Bare, O., Huang, X., Spiegelman, B. and Wu, Z. (2009) PPARδ agonism activates fatty acid oxidation via PGC-1α but does not increase mitochondrial gene expression and function. J. Biol. Chem. 284, 18624-18633
44. Dressel, U., Allen, T.L., Pippal, J.B., Rohde, P.R., Lau, P. and Muscat, G.E. (2003) The peroxisome proliferator-activated receptor beta/delta agonist, GW501516, regulates the expression of genes involved in lipid catabolism and energy uncoupling in skeletal muscle cells. Mol. Endocrinol. 17, 2477-2493
45. Wang, Y.X., Zhang, C.L., Yu, R.T., Cho, H.K., Nelson, M.C., Bayuga-Ocampo, C.R., Ham, J., Kang, H. and Evans, R.M. (2004) Regulation of muscle fiber type and running endurance by PPARdelta. PLoS Biol 2, e294
46. Lee, C.H., Olson, P., Hevener, A., Mehl, I., Chong, L.W., Olefsky, J.M., Gonzalez, F.J., Ham, J., Kang, H., Peters, J.M. et al. (2006) PPARdelta regulates glucose metabolism and insulin sensitivity. Proc. Natl. Acad. Sci. U.S.A. 103, 3444-3449
47. Riserus, U., Sprecher, D., Johnson, T., Olson, E., Hirschberg, S., Liu, A., Fang, Z., Hegde, P., Richards, D., Sarov-Blat, L. et al. (2008) Activation of peroxisome proliferator-activated receptor (PPAR)delta promotes reversal of multiple metabolic abnormalities, reduces oxidative stress, and increases fatty acid oxidation in moderately obese men. Diabetes 57, 332-339
48. Cariou, B., Hanf, R., Lambert-Porcheron, S., Zair, Y., Sauvinet, V., Noel, B., Flet, L., Vidal, H., Staels, B. and Laville, M. (2013) Dual peroxisome proliferator-activated receptor alpha/delta agonist GFT505 improves hepatic and peripheral insulin sensitivity in abdominally obese subjects. Diabetes Care 36, 2923-2930
49. Gan, Z., Burkart-Hartman, E.M., Han, D.H., Finck, B., Leone, T.C., Smith, E.Y., Ayala, J.E., Holloszy, J. and Kelly, D.P. (2011) The nuclear receptor PPARbeta/delta programs muscle glucose metabolism in cooperation with AMPK and MEF2. Genes Dev. 25, 2619-2630
50. Luquet, S., Lopez-Soriano, J., Holst, D., Fredenrich, A., Melki, J., Rassoulzadegan, M. and Grimaldi, P.A. (2003) Peroxisome proliferator-activated receptor delta controls muscle development and oxidative capability. FASEB J. 17, 2299-2301
51. Schuler, M., Ali, F., Chambon, C., Duteil, D., Bornert, J.M., Tardivel, A., Desvergne, B., Wahli, W., Chambon, P. and Metzger, D. (2006) PGC1alpha expression is controlled in skeletal muscles by PPARbeta, whose ablation results in fiber-type switching, obesity, and type 2 diabetes. Cell Metab. 4, 407-414
52. Perez-Schindler, J., Svensson, K., Vargas-Fernandez, E., Santos, G., Wahli, W. and Handschin, C. (2014) The coactivator PGC-1alpha regulates skeletal muscle oxidative metabolism independently of the nuclear receptor PPARbeta/delta in sedentary mice fed a regular chow diet. Diabetologia 57, 2405-2412
53. Garcia-Roves, P., Huss, J.M., Han, D.H., Hancock, C.R., Iglesias-Gutierrez, E., Chen, M. and Holloszy, J.O. (2007) Raising plasma fatty acid concentration induces increased biogenesis of mitochondria in skeletal muscle. Proc. Natl. Acad. Sci. U.S.A. 104, 10709-10713
54. Giguere, V., Yang, N., Segui, P. and Evans, R.M. (1988) Identification of a new class of steroid hormone receptors. Nature 331, 91-94
55. Huss, J.M., Torra, I.P., Staels, B., Giguere, V. and Kelly, D.P. (2004) Estrogen-related receptor alpha directs peroxisome proliferator-activated receptor alpha signaling in the transcriptional control of energy metabolism in cardiac and skeletal muscle. Mol. Cell. Biol. 24, 9079-9091
56. Audet-Walsh, E. and Giguere, V. (2015) The multiple universes of estrogen-related receptor alpha and gamma in metabolic control and related diseases. Acta Pharmacol. Sin. 36, 51-61
57. Schreiber, S.N., Knutti, D., Brogli, K., Uhlmann, T. and Kralli, A. (2003) The transcriptional coactivator PGC-1 regulates the expression and activity of the orphan nuclear receptor estrogen-related receptor alpha (ERRalpha). J. Biol. Chem. 278, 9013-9018
58. Huss, J.M., Kopp, R.P. and Kelly, D.P. (2002) Peroxisome proliferator-activated receptor coactivator-1alpha (PGC-1alpha) coactivates the cardiac-enriched nuclear receptors estrogen-related receptor-alpha and-gamma. Identification of novel leucine-rich interaction motif within PGC-1alpha. J. Biol. Chem. 277, 40265-40274
59. Perez-Schindler, J., Summermatter, S., Salatino, S., Zorzato, F., Beer, M., Balwierz, P.J., van Nimwegen, E., Feige, J.N., Auwerx, J. and Handschin, C. (2012) The corepressor NCoR1 antagonizes PGC-1alpha and estrogen-related receptor alpha in the regulation of skeletal muscle function and oxidative metabolism. Mol. Cell. Biol. 32, 4913-4924
60. Mootha, V.K., Handschin, C., Arlow, D., Xie, X., St Pierre, J., Sihag, S., Yang, W., Altshuler, D., Puigserver, P., Patterson, N et al. (2004) Erralpha and Gabpa/b specify PGC-1alpha-dependent oxidative phosphorylation gene expression that is altered in diabetic muscle. Proc. Natl. Acad. Sci. U.S.A. 101, 6570-6575
61. Schreiber, S.N., Emter, R., Hock, M.B., Knutti, D., Cardenas, J., Podvinec, M., Oakeley, E.J. and Kralli, A. (2004) The estrogen-related receptor alpha (ERRalpha) functions in PPARgamma coactivator 1alpha (PGC-1alpha)-induced mitochondrial biogenesis. Proc. Natl. Acad. Sci. U.S.A. 101, 6472-6477
62. Villena, J.A., Hock, M.B., Chang, W.Y., Barcas, J.E., Giguere, V. and Kralli, A. (2007) Orphan nuclear receptor estrogen-related receptor alpha is essential for adaptive thermogenesis. Proc. Natl. Acad. Sci. U.S.A. 104, 1418-1423
63. Perry, M.C., Dufour, C.R., Tam, I.S., B'Chir, W. and Giguere, V. (2014) Estrogen-related receptor-alpha coordinates transcriptional programs essential for exercise tolerance and muscle fitness. Mol. Endocrinol. 28, 2060-2071
64. Rangwala, S.M., Wang, X., Calvo, J.A., Lindsley, L., Zhang, Y., Deyneko, G., Beaulieu, V., Gao, J., Turner, G. and Markovits, J. (2010) Estrogen-related receptor gamma is a key regulator of muscle mitochondrial activity and oxidative capacity. J. Biol. Chem. 285, 22619-22629
65. Narkar, V.A., Fan, W., Downes, M., Yu, R.T., Jonker, J.W., Alaynick, W.A., Banayo, E., Karunasiri, M.S., Lorca, S. and Evans, R.M. (2011) Exercise and PGC-1alpha-independent synchronization of type I muscle metabolism and vasculature by ERRgamma. Cell Metab. 13, 283-293
66. Murray, J., Auwerx, J. and Huss, J.M. (2013) Impaired myogenesis in estrogen-related receptor gamma (ERRgamma)-deficient skeletal myocytes due to oxidative stress. FASEB J. 27, 135-150
67. Pearen, M.A. and Muscat, G.E. (2010) Minireview: Nuclear hormone receptor 4A signaling: implications for metabolic disease. Mol. Endocrinol. 24, 1891-1903
68. Myers, S.A., Eriksson, N., Burow, R., Wang, S.C. and Muscat, G.E. (2009) Beta-adrenergic signaling regulates NR4A nuclear receptor and metabolic gene expression in multiple tissues. Mol. Cell. Endocrinol. 309, 101-108
69. Mahoney, D.J., Parise, G., Melov, S., Safdar, A. and Tarnopolsky, M.A. (2005) Analysis of global mRNA expression in human skeletal muscle during recovery from endurance exercise. FASEB J. 19, 1498-1500
70. Catoire, M., Mensink, M., Boekschoten, M.V., Hangelbroek, R., Muller, M., Schrauwen, P. and Kersten, S. (2012) Pronounced effects of acute endurance exercise on gene expression in resting and exercising human skeletal muscle. PLoS One 7, e51066
71. Kawasaki, E., Hokari, F., Sasaki, M., Sakai, A., Koshinaka, K. and Kawanaka, K. (2009) Role of local muscle contractile activity in the exercise-induced increase in NR4A receptor mRNA expression. J. Appl. Physiol. 106, 1826-1831
72. Nader, G.A., von Walden, F., Liu, C., Lindvall, J., Gutmann, L., Pistilli, E.E. and Gordon, P.M. (2014) Resistance exercise training modulates acute gene expression during human skeletal muscle hypertrophy. J. Appl. Physiol. 116, 693-702
73. Fu, Y., Luo, L., Luo, N., Zhu, X. and Garvey, W.T. (2007) NR4A orphan nuclear receptors modulate insulin action and the glucose transport system: potential role in insulin resistance. J. Biol. Chem. 282, 31525-31533
74. Kanzleiter, T., Wilks, D., Preston, E., Ye, J., Frangioudakis, G. and Cooney, G.J. (2009) Regulation of the nuclear hormone receptor nur77 in muscle: influence of exercise-activated pathways in vitro and obesity in vivo. Biochim. Biophys. Acta 1792, 777-782
75. Chao, L.C., Zhang, Z., Pei, L., Saito, T., Tontonoz, P. and Pilch, P.F. (2007) Nur77 coordinately regulates expression of genes linked to glucose metabolism in skeletal muscle. Mol. Endocrinol. 21, 2152-2163
76. Maxwell, M.A., Cleasby, M.E., Harding, A., Stark, A., Cooney, G.J. and Muscat, G.E. (2005) Nur77 regulates lipolysis in skeletal muscle cells. Evidence for cross-talk between the beta-adrenergic and an orphan nuclear hormone receptor pathway. J. Biol. Chem. 280, 12573-12584
77. Chao, L.C., Wroblewski, K., Ilkayeva, O.R., Stevens, R.D., Bain, J., Meyer, G.A., Schenk, S., Martinez, L., Vergnes, L., Narkar, V.A., Drew, B.G. et al. (2012) Skeletal muscle Nur77 expression enhances oxidative metabolism and substrate utilization. J. Lipid Res. 53, 2610-2619
78. Chao, L.C., Wroblewski, K., Zhang, Z., Pei, L., Vergnes, L., Ilkayeva, O.R., Ding, S.Y., Reue, K., Watt, M.J., Newgard, C.B. et al. (2009) Insulin resistance and altered systemic glucose metabolism in mice lacking Nur77. Diabetes 58, 2788-2796
79. Pearen, M.A., Myers, S.A., Raichur, S., Ryall, J.G., Lynch, G.S. and Muscat, G.E. (2008) The orphan nuclear receptor, NOR-1, a target of beta-adrenergic signaling, regulates gene expression that controls oxidative metabolism in skeletal muscle. Endocrinology 149, 2853-2865
80. Pearen, M.A., Eriksson, N.A., Fitzsimmons, R.L., Goode, J.M., Martel, N., Andrikopoulos, S. and Muscat, G.E. (2012) The nuclear receptor, Nor-1, markedly increases type II oxidative muscle fibers and resistance to fatigue. Mol. Endocrinol. 26, 372-384
81. Pearen, M.A., Goode, J.M., Fitzsimmons, R.L., Eriksson, N.A., Thomas, G.P., Cowin, G.J., Wang, S.C., Tuong, Z.K. and Muscat, G.E. (2013) Transgenic muscle-specific Nor-1 expression regulates multiple pathways that effect adiposity, metabolism, and endurance. Mol. Endocrinol. 27, 1897-1917
82. Liu, Q., Zhu, X., Xu, L., Fu, Y. and Garvey, W.T. (2013) 6-Mercaptopurine augments glucose transport activity in skeletal muscle cells in part via a mechanism dependent upon orphan nuclear receptor NR4A3. Am. J. Physiol. Endocrinol. Metab. 305, E1081-E1092
83. Crowther, L.M., Wang, S.C., Eriksson, N.A., Myers, S.A., Murray, L.A. and Muscat, G.E. (2011) Chicken ovalbumin upstream promoter-transcription factor II regulates nuclear receptor, myogenic, and metabolic gene expression in skeletal muscle cells. Physiol. Genomics 43, 213-227
84. Muscat, G.E., Rea, S. and Downes, M. (1995) Identification of a regulatory function for an orphan receptor in muscle: COUP-TF II affects the expression of the myoD gene family during myogenesis. Nucleic Acids Res. 23, 1311-1318
85. Myers, S.A., Wang, S.C. and Muscat, G.E. (2006) The chicken ovalbumin upstream promoter-transcription factors modulate genes and pathways involved in skeletal muscle cell metabolism. J. Biol. Chem. 281, 24149-24160
86. Everett, L.J. and Lazar, M.A. (2014) Nuclear receptor Rev-erbalpha: up, down, and all around. Trends Endocrinol. Metab. 25, 586-592
87. Pircher, P., Chomez, P., Yu, F., Vennstrom, B. and Larsson, L. (2005) Aberrant expression of myosin isoforms in skeletal muscles from mice lacking the rev-erbAalpha orphan receptor gene. Am. J. Physiol. Regul. Integr. Comp. Physiol. 288, R482-R490
88. Woldt, E., Sebti, Y., Solt, L.A., Duhem, C., Lancel, S., Eeckhoute, J., Hesselink, M.K., Paquet, C., Delhaye, S., Shin, Y. et al. (2013) Rev-erb-alpha modulates skeletal muscle oxidative capacity by regulating mitochondrial biogenesis and autophagy. Nat. Med. 19, 1039-1046
89. Liu, C., Li, S., Liu, T., Borjigin, J. and Lin, J.D. (2007) Transcriptional coactivator PGC-1alpha integrates the mammalian clock and energy metabolism. Nature 447, 477-481
90. Solt, L.A., Wang, Y., Banerjee, S., Hughes, T., Kojetin, D.J., Lundasen, T., Shin, Y., Liu, J., Cameron, M.D., Noel, R. et al. (2012) Regulation of circadian behaviour and metabolism by synthetic REV-ERB agonists. Nature 485, 62-68
91. Russell, A.P., Hesselink, M.K., Lo, S.K. and Schrauwen, P. (2005) Regulation of metabolic transcriptional co-activators and transcription factors with acute exercise. FASEB J. 19, 986-988
92. Barres, R., Yan, J., Egan, B., Treebak, J.T., Rasmussen, M., Fritz, T., Caidahl, K., Krook, A., O'Gorman, D.J. and Zierath, J.R. (2012) Acute exercise remodels promoter methylation in human skeletal muscle. Cell Metab. 15, 405-411
93. Narkar, V.A., Downes, M., Yu, R.T., Embler, E., Wang, Y.X., Banayo, E., Mihaylova, M.M., Nelson, M.C., Zou, Y., Juguilon, H. et al. (2008) AMPK and PPARdelta agonists are exercise mimetics. Cell 134, 405-415
94. Philp, A., MacKenzie, M.G., Belew, M.Y., Towler, M.C., Corstorphine, A., Papalamprou, A., Hardie, D.G. and Baar, K. (2013) Glycogen content regulates peroxisome proliferator activated receptor-partial differential (PPAR-partial differential) activity in rat skeletal muscle. PLoS One 8, e77200
95. Cartoni, R., Leger, B., Hock, M.B., Praz, M., Crettenand, A., Pich, S., Ziltener, J.L., Luthi, F., Deriaz, O., Zorzano, A. et al. (2005) Mitofusins 1/2 and ERRalpha expression are increased in human skeletal muscle after physical exercise. J. Physiol. 567, 349-358
96. Wallace, M.A., Hock, M.B., Hazen, B.C., Kralli, A., Snow, R.J. and Russell, A.P. (2011) Striated muscle activator of Rho signalling (STARS) is a PGC-1alpha/oestrogen-related receptor-alpha target gene and is upregulated in human skeletal muscle after endurance exercise. J. Physiol. 589, 2027-2039
97. Egan, B., O'Connor, P.L., Zierath, J.R. and O'Gorman, D.J. (2013) Time course analysis reveals gene-specific transcript and protein kinetics of adaptation to short-term aerobic exercise training in human skeletal muscle. PLoS One 8, e74098
98. Wrann, C.D., White, J.P., Salogiannnis, J., Laznik-Bogoslavski, D., Wu, J., Ma, D., Lin, J.D., Greenberg, M.E. and Spiegelman, B.M. (2013) Exercise induces hippocampal BDNF through a PGC-1alpha/FNDC5 pathway. Cell. Metab. 18, 649-659
99. Cho, Y., Hazen, B.C., Russell, A.P. and Kralli, A. (2013) PGC-1 and ERR-induced Regulator in Muscle 1 (PERM1) is a tissue-specific regulator of oxidative capacity in skeletal muscle cells. J. Biol. Chem. 1833, 3112-3123
100. Stephenson, E.J., Stepto, N.K., Koch, L.G., Britton, S.L. and Hawley, J.A. (2012) Divergent skeletal muscle respiratory capacities in rats artificially selected for high and low running ability: a role for Nor1? J. Appl. Physiol. 113, 1403-1412
101. Lessard, S.J., Rivas, D.A., Stephenson, E.J., Yaspelkis, 3rd, B.B., Koch, L.G., Britton, S.L. and Hawley, J.A. (2011) Exercise training reverses impaired skeletal muscle metabolism induced by artificial selection for low aerobic capacity. Am. J. Physiol. Regul. Integr. Comp. Physiol. 300, R175-R182
102. Choi, C.S., Befroy, D.E., Codella, R., Kim, S., Reznick, R.M., Hwang, Y.J., Liu, Z.X., Lee, H.Y., Distefano, A., Samuel, V.T. et al. (2008) Paradoxical effects of increased expression of PGC-1alpha on muscle mitochondrial function and insulin-stimulated muscle glucose metabolism. Proc. Natl. Acad. Sci. U.S.A. 105, 19926-19931
103. Summermatter, S., Shui, G., Maag, D., Santos, G., Wenk, M.R. and Handschin, C. (2013) PGC-1alpha improves glucose homeostasis in skeletal muscle in an activity-dependent manner. Diabetes 62, 85-95
104. Wong, K.E., Mikus, C.R., Slentz, D.H., Seiler, S.E., DeBalsi, K.L., Ilkayeva, O.R., Crain, K.I., Kinter, M.T., Kien, C.L., Stevens, R.D. et al. (2014) Muscle-specific overexpression of PGC-1alpha does not augment metabolic improvements in response to exercise and caloric restriction. Diabetes 64, 1532-1543